Vanzacaftor Calcium is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector used to treat cystic fibrosis by improving the folding and function of defective CFTR proteins. As a small… Read more
Vanzacaftor Calcium is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector used to treat cystic fibrosis by improving the folding and function of defective CFTR proteins. As a small molecule corrector, this therapeutic agent restores chloride channel activity in patients with specific genetic mutations, addressing the underlying causes of the condition. This category provides essential materials for pharmaceutical research and quality assurance, including high-quality reference standards, synthetic impurities, metabolites, and stable isotope-labelled compounds. These products are critical for laboratories performing rigorous analytical method development, impurity profiling, and bioanalytical quantification. By utilizing these precise reference materials, researchers can ensure accurate purity assessment and reliable method validation throughout the drug development lifecycle, supporting compliance with regulatory quality control standards for this complex therapeutic agent.